These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 13959

  • 1. Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine.
    Asberg M, Ringberger VA, Sjöqvist F, Thorén P, Träskman L, Tuck JR.
    Clin Pharmacol Ther; 1977 Feb; 21(2):201-7. PubMed ID: 13959
    [Abstract] [Full Text] [Related]

  • 2. Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients.
    Siwers B, Ringberger VA, Tuck JR, Sjöqvist F.
    Clin Pharmacol Ther; 1977 Feb; 21(2):194-200. PubMed ID: 837638
    [Abstract] [Full Text] [Related]

  • 3. Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder.
    Mårtensson B, Wägner A, Beck O, Brodin K, Montero D, Asberg M.
    Acta Psychiatr Scand; 1991 Feb; 83(2):125-33. PubMed ID: 1708190
    [Abstract] [Full Text] [Related]

  • 4. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A, Ross SB, Jostell KG, Sjöquist B.
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [Abstract] [Full Text] [Related]

  • 5. Treatment of depression with tricyclic drugs--pharmacokinetic and pharmacodynamic aspects.
    Asberg M.
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):18-26. PubMed ID: 10583
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K.
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [Abstract] [Full Text] [Related]

  • 11. Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients.
    Nordin C.
    Acta Psychiatr Scand; 1988 Dec; 78(6):720-9. PubMed ID: 2464903
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK, Nordin C, Jönsson EG, Engberg G, Linderholm KR, Erhardt S.
    J Psychiatr Res; 2007 Dec; 41(1-2):144-51. PubMed ID: 16434056
    [Abstract] [Full Text] [Related]

  • 13. Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.
    Mårtensson B, Nyberg S, Toresson G, Brodin E, Bertilsson L.
    Acta Psychiatr Scand; 1989 Jun; 79(6):586-96. PubMed ID: 2475012
    [Abstract] [Full Text] [Related]

  • 14. Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers.
    Andreou D, Saetre P, Kähler AK, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG.
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):700-4. PubMed ID: 21295953
    [Abstract] [Full Text] [Related]

  • 15. Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects.
    Thorén P, Asberg M, Bertilsson L, Mellström B, Sjöqvist F, Träskman L.
    Arch Gen Psychiatry; 1980 Nov; 37(11):1289-94. PubMed ID: 6159865
    [Abstract] [Full Text] [Related]

  • 16. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ, Scheinin M, Golden RN, Rudorfer MV, Cowdry RW, Calil HM, Ross RJ, Linnoila M.
    Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
    [Abstract] [Full Text] [Related]

  • 17. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ, Koslow SH, Seifert WE, Caprioli RM, Singer HS.
    Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
    [Abstract] [Full Text] [Related]

  • 18. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M, Alexiou GA, Liakopoulou M, Papakonstantinou E, Pitsouni D, Alevizopoulos GA.
    J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases.
    Wester P, Bergström U, Eriksson A, Gezelius C, Hardy J, Winblad B.
    J Neurochem; 1990 Apr; 54(4):1148-56. PubMed ID: 1968956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.